Ca2+ sensor proteins in spontaneous release and synaptic plasticity: Limited contribution of Doc2c, rabphilin-3a and synaptotagmin 7 in hippocampal glutamatergic neurons-Reference-Cited by-同舟云学术

Ca2+ sensor proteins in spontaneous release and synaptic plasticity: Limited contribution of Doc2c, rabphilin-3a and synaptotagmin 7 in hippocampal glutamatergic neurons

Published:2021-04 Issue: Volume:112 Page:103613
ISSN:1044-7431
Container-title:Molecular and Cellular Neuroscience
language:en
Short-container-title:Molecular and Cellular Neuroscience

Author:

Bourgeois-Jaarsma Quentin,Miaja Hernandez Pablo,Groffen Alexander J.

Funder

ZonMw

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience,Molecular Biology

Reference164 articles.

1. Close membrane-membrane proximity induced by Ca2+-dependent multivalent binding of synaptotagmin-1 to phospholipids;Araç;Nat. Struct. Mol. Biol.,2006

2. Delayed release of neurotransmitter from cerebellar granule cells;Atluri;J. Neurosci.,1998

3. Synaptotagmin-1 and synaptotagmin-7 trigger synchronous and asynchronous phases of neurotransmitter release;Bacaj;Neuron,2013

4. C2A activates a cryptic Ca2+-triggered membrane penetration activity within the C2B domain of synaptotagmin I;Bai;Proc. Natl. Acad. Sci.,2002

5. PIP2 increases the speed of response of synaptotagmin and steers its membrane-penetration activity toward the plasma membrane;Bai;Nat. Struct. Mol. Biol.,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on novel and emerging therapeutic targets in Parkinson’s disease;Metabolic Brain Disease;2024-07-27

2. Identification and Experimental Validation of Parkinson’s Disease with Major Depressive Disorder Common Genes;Molecular Neurobiology;2023-07-07

3. Identification and Experimental Validation of Parkinson’s Disease with Major Depressive Disorder Common Genes;2022-12-22

4. Synaptotagmins 1 and 7 in vesicle release from rods of mouse retina;Experimental Eye Research;2022-12

5. Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson’s disease;Pharmacological Research;2022-09